Biogen Inc.

NasdaqGS:BIIB

Market Cap

USD 18.82 B

Share Price

USD 128.46

Avg Daily Volume

1,561,840

Change (1 day)

0.75%

Change (1 year)

-42.91%

Change (YTD)

-16.00%

Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 17.85%

Biogen Inc. EBT Margin is 17.85% for the Trailing 12 Months (TTM) ending March 31, 2025, a 30.36% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 13.69%, a -62.43% change year over year.
  • Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 36.45%, a 142.57% change year over year.
  • Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 15.02%, a -50.36% change year over year.
  • Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 30.27%, a -37.32% change year over year.
Key Data
Date EBT Margin Operating Income Margin Gross Profit Margin EBIT Margin